Literature DB >> 30541847

Cross-Presentation of Skin-Targeted Recombinant Adeno-associated Virus 2/1 Transgene Induces Potent Resident Memory CD8+ T Cell Responses.

David-Alexandre Gross1, Alexandre Ghenassia2, Laurent Bartolo2, Dominique Urbain2, Sofia Benkhelifa-Ziyyat3, Stéphanie Lorain3, Jean Davoust2, Pascal Chappert1,4.   

Abstract

A key aspect to consider for vaccinal protection is the induction of a local line of defense consisting of nonrecirculating tissue-resident memory T cells (TRM), in parallel to the generation of systemic memory CD8+ T cell responses. The potential to induce TRM has now been demonstrated for a number of pathogens and viral vectors. This potential, however, has never been tested for recombinant adeno-associated virus (rAAV) vectors, which are weakly inflammatory and poor transducer of dendritic cells. Using a model rAAV2/1-based vaccine, we determined that a single intradermal immunization with rAAV2/1 vectors in mice induces fully functional TRM at the local site of immunization. The optimal differentiation of rAAV-induced transgene-specific skin TRM was dependent on local transgene expression and additional CD4+ T cell help. Transgene expression in dendritic cells, however, appeared to be dispensable for the priming of transgene-specific skin TRM, suggesting that this process solely depends on the cross-presentation of transgene products. Overall, this study provides needed information to properly assess rAAV vectors as T cell-inducing vaccine carriers.IMPORTANCE rAAVs display numerous characteristics that could make them extremely attractive as vaccine carriers, including an excellent safety profile in humans and great flexibility regarding serotypes and choice of target tissue. Studies addressing the ability of rAAV to induce protective T cell responses, however, are scarce. Notably, the potential to induce a tissue-resident memory T cell response has never been described for rAAV vectors, strongly limiting further interest for their use as vaccine carriers. Using a model rAAV2/1 vaccine delivered to the skin, our study demonstrated that rAAV vectors can induce bona fide skin resident TRM and provides additional clues regarding the cellular mechanisms underlying this process. These results will help widen the field of rAAV applications.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  cross-presentation; rAAV vaccine; resident memory T cells; skin

Mesh:

Substances:

Year:  2019        PMID: 30541847      PMCID: PMC6384067          DOI: 10.1128/JVI.01334-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation.

Authors:  Laura K Mackay; Angus T Stock; Joel Z Ma; Claerwen M Jones; Stephen J Kent; Scott N Mueller; William R Heath; Francis R Carbone; Thomas Gebhardt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

2.  Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer.

Authors:  Brian D Brown; Mary Anna Venneri; Anna Zingale; Lucia Sergi Sergi; Luigi Naldini
Journal:  Nat Med       Date:  2006-04-23       Impact factor: 53.440

3.  Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus.

Authors:  Thomas Gebhardt; Linda M Wakim; Liv Eidsmo; Patrick C Reading; William R Heath; Francis R Carbone
Journal:  Nat Immunol       Date:  2009-03-22       Impact factor: 25.606

4.  Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat.

Authors:  Sharon Reimsnider; Fredric P Manfredsson; Nicholas Muzyczka; Ronald J Mandel
Journal:  Mol Ther       Date:  2007-06-12       Impact factor: 11.454

5.  Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles.

Authors:  Angela Pizzolla; Thi Ho Nguyen; Sneha Sant; Jade Jaffar; Tom Loudovaris; Stuart I Mannering; Paul G Thomas; Glen P Westall; Katherine Kedzierska; Linda M Wakim
Journal:  J Clin Invest       Date:  2018-01-08       Impact factor: 14.808

6.  T cell memory. Skin-resident memory CD8⁺ T cells trigger a state of tissue-wide pathogen alert.

Authors:  Silvia Ariotti; Marc A Hogenbirk; Feline E Dijkgraaf; Lindy L Visser; Mirjam E Hoekstra; Ji-Ying Song; Heinz Jacobs; John B Haanen; Ton N Schumacher
Journal:  Science       Date:  2014-08-28       Impact factor: 47.728

7.  Intradermal Immunization with rAAV1 Vector Induces Robust Memory CD8+ T Cell Responses Independently of Transgene Expression in DCs.

Authors:  Alexandre Ghenassia; David-Alexandre Gross; Stéphanie Lorain; Fabiola Tros; Dominique Urbain; Sofia Benkhelifa-Ziyyat; Alain Charbit; Jean Davoust; Pascal Chappert
Journal:  Mol Ther       Date:  2017-07-15       Impact factor: 11.454

8.  SPICE: exploration and analysis of post-cytometric complex multivariate datasets.

Authors:  Mario Roederer; Joshua L Nozzi; Martha C Nason
Journal:  Cytometry A       Date:  2011-01-07       Impact factor: 4.355

9.  The Salivary Gland Acts as a Sink for Tissue-Resident Memory CD8(+) T Cells, Facilitating Protection from Local Cytomegalovirus Infection.

Authors:  Jenny Tosca Thom; Thomas Christian Weber; Senta Maria Walton; Nicole Torti; Annette Oxenius
Journal:  Cell Rep       Date:  2015-10-29       Impact factor: 9.423

10.  Antigen-dependent competition shapes the local repertoire of tissue-resident memory CD8+ T cells.

Authors:  Andreas Muschaweckh; Veit R Buchholz; Anne Fellenzer; Christian Hessel; Paul-Albert König; Sha Tao; Ronny Tao; Mathias Heikenwälder; Dirk H Busch; Thomas Korn; Wolfgang Kastenmüller; Ingo Drexler; Georg Gasteiger
Journal:  J Exp Med       Date:  2016-11-29       Impact factor: 14.307

View more
  2 in total

1.  Dual muscle-liver transduction imposes immune tolerance for muscle transgene engraftment despite preexisting immunity.

Authors:  Laurent Bartolo; Stéphanie Li Chung Tong; Pascal Chappert; Dominique Urbain; Fanny Collaud; Pasqualina Colella; Isabelle Richard; Giuseppe Ronzitti; Jocelyne Demengeot; David A Gross; Federico Mingozzi; Jean Davoust
Journal:  JCI Insight       Date:  2019-06-06

2.  An Engineered AAV6-Based Vaccine Induces High Cytolytic Anti-Tumor Activity by Directly Targeting DCs and Improves Ag Presentation.

Authors:  Karina Krotova; Andrew Day; George Aslanidi
Journal:  Mol Ther Oncolytics       Date:  2019-10-07       Impact factor: 7.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.